Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity.
Valentini G, Marcoccia A, Cuomo G, Vettori S, Iudici M, Bondanini F, Santoriello C, Ciani A, Cozzolino D, De Matteis GM, Cappabianca S, Vitelli F, Spanò A. Valentini G, et al. Among authors: vitelli f. Arthritis Care Res (Hoboken). 2014 Oct;66(10):1520-7. doi: 10.1002/acr.22304. Arthritis Care Res (Hoboken). 2014. PMID: 24515450 Free article.
Early systemic sclerosis: marker autoantibodies and videocapillaroscopy patterns are each associated with distinct clinical, functional and cellular activation markers.
Valentini G, Marcoccia A, Cuomo G, Vettori S, Iudici M, Bondanini F, Santoriello C, Ciani A, Cozzolino D, De Matteis GM, Cappabianca S, Vitelli F, Spanò A. Valentini G, et al. Among authors: vitelli f. Arthritis Res Ther. 2013;15(3):R63. doi: 10.1186/ar4236. Arthritis Res Ther. 2013. PMID: 23718566 Free PMC article.
Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo- Controlled Clinical Trial.
Di Stadio A, D'Ascanio L, Vaira LA, Cantone E, De Luca P, Cingolani C, Motta G, De Riu G, Vitelli F, Spriano G, De Vincentiis M, Camaioni A, La Mantia I, Ferreli F, Brenner MJ. Di Stadio A, et al. Among authors: vitelli f. Curr Neuropharmacol. 2022;20(10):2001-2012. doi: 10.2174/1570159X20666220420113513. Curr Neuropharmacol. 2022. PMID: 35450527 Free PMC article. Clinical Trial.
Olfactory Dysfunction, Headache, and Mental Clouding in Adults with Long-COVID-19: What Is the Link between Cognition and Olfaction? A Cross-Sectional Study.
Di Stadio A, Brenner MJ, De Luca P, Albanese M, D'Ascanio L, Ralli M, Roccamatisi D, Cingolani C, Vitelli F, Camaioni A, Di Girolamo S, Bernitsas E. Di Stadio A, et al. Among authors: vitelli f. Brain Sci. 2022 Jan 24;12(2):154. doi: 10.3390/brainsci12020154. Brain Sci. 2022. PMID: 35203918 Free PMC article.
Comparison of Tumor Seeding and Recurrence Rate After Laparoscopic vs. Open Nephroureterectomy for Upper Urinary Tract Transitional Cell Carcinoma.
Morselli S, Vitelli FD, Verrini G, Sebastianelli A, Campi R, Liaci A, Spatafora P, Barzaghi P, Ferrari G, Gacci M, Serni S, Brausi M. Morselli S, et al. Among authors: vitelli fd. Front Surg. 2021 Dec 23;8:769527. doi: 10.3389/fsurg.2021.769527. eCollection 2021. Front Surg. 2021. PMID: 35004836 Free PMC article.
Randomized clinical trial "olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin": preliminary results.
D'Ascanio L, Vitelli F, Cingolani C, Maranzano M, Brenner MJ, Di Stadio A. D'Ascanio L, et al. Among authors: vitelli f. Eur Rev Med Pharmacol Sci. 2021 Jun;25(11):4156-4162. doi: 10.26355/eurrev_202106_26059. Eur Rev Med Pharmacol Sci. 2021. PMID: 34156697 Free article. Clinical Trial.
Green light laser enucleation of the prostate with early apical release is safe and effective: single center experience and revision of the literature.
Ferrari G, Rabito S, Gatti L, Ntep NN, Vitelli FD, Marchioni M, Rocco BM, Micali S, Ferrari R, Cindolo L. Ferrari G, et al. Among authors: vitelli fd. Minerva Urol Nephrol. 2022 Aug;74(4):467-474. doi: 10.23736/S2724-6051.21.04145-X. Epub 2021 Mar 29. Minerva Urol Nephrol. 2022. PMID: 33781016 Free article.
The role of prostate-specific antigen density in men with low-risk prostate cancer suitable for active surveillance: results of a prospective observational study.
Sebastianelli A, Morselli S, Vitelli FD, Gabellini L, Tasso G, Venturini S, Cito G, Vignolini G, Raspollini MR, Gacci M, Serni S. Sebastianelli A, et al. Among authors: vitelli fd. Prostate Int. 2019 Dec;7(4):139-142. doi: 10.1016/j.prnil.2019.02.001. Epub 2019 Feb 22. Prostate Int. 2019. PMID: 31970138 Free PMC article.
50 results